Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Balance Sheet
Balance Sheet Decomposition
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc
Balance Sheet
Catalyst Pharmaceuticals Inc
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
20
|
16
|
12
|
8
|
6
|
6
|
1
|
2
|
9
|
28
|
14
|
58
|
17
|
90
|
130
|
171
|
298
|
138
|
518
|
|
| Cash Equivalents |
0
|
1
|
20
|
16
|
12
|
8
|
6
|
6
|
1
|
2
|
9
|
28
|
14
|
58
|
17
|
90
|
130
|
171
|
298
|
138
|
518
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
22
|
30
|
30
|
27
|
27
|
37
|
5
|
10
|
20
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
6
|
7
|
10
|
54
|
65
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
6
|
7
|
10
|
54
|
65
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
8
|
7
|
16
|
20
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
2
|
1
|
1
|
2
|
4
|
8
|
4
|
5
|
13
|
21
|
|
| Total Current Assets |
0
|
1
|
21
|
17
|
12
|
8
|
6
|
6
|
17
|
25
|
44
|
60
|
42
|
85
|
55
|
111
|
159
|
210
|
321
|
219
|
624
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
4
|
4
|
4
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
194
|
157
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
16
|
22
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
24
|
19
|
37
|
46
|
|
| Total Assets |
0
N/A
|
1
+300%
|
21
+2 475%
|
17
-19%
|
12
-28%
|
8
-33%
|
6
-28%
|
6
+7%
|
17
+171%
|
25
+51%
|
44
+73%
|
60
+37%
|
42
-31%
|
85
+105%
|
60
-29%
|
112
+86%
|
192
+71%
|
238
+24%
|
376
+58%
|
470
+25%
|
851
+81%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
2
|
2
|
4
|
4
|
3
|
4
|
15
|
17
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
4
|
2
|
1
|
2
|
7
|
17
|
18
|
24
|
32
|
48
|
99
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
22
|
14
|
5
|
|
| Total Current Liabilities |
0
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
2
|
2
|
6
|
3
|
2
|
4
|
10
|
24
|
23
|
27
|
58
|
76
|
121
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
3
|
1
|
0
|
0
|
0
|
1
|
0
|
4
|
18
|
6
|
3
|
|
| Total Liabilities |
0
N/A
|
0
+200%
|
1
+167%
|
0
-50%
|
2
+275%
|
0
-80%
|
0
N/A
|
3
+733%
|
2
-12%
|
4
+82%
|
9
+118%
|
5
-47%
|
2
-48%
|
4
+83%
|
10
+120%
|
25
+155%
|
23
-8%
|
31
+36%
|
75
+143%
|
82
+9%
|
124
+51%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
3
|
6
|
10
|
21
|
28
|
32
|
38
|
42
|
54
|
70
|
90
|
108
|
127
|
161
|
129
|
54
|
26
|
50
|
121
|
285
|
|
| Additional Paid In Capital |
1
|
3
|
26
|
26
|
31
|
35
|
37
|
42
|
57
|
76
|
105
|
146
|
147
|
207
|
211
|
216
|
223
|
233
|
250
|
266
|
442
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
+300%
|
20
+4 850%
|
16
-18%
|
11
-35%
|
8
-28%
|
6
-28%
|
4
-31%
|
15
+284%
|
21
+47%
|
35
+64%
|
56
+58%
|
39
-29%
|
81
+106%
|
51
-37%
|
88
+72%
|
170
+94%
|
207
+22%
|
300
+45%
|
388
+29%
|
728
+88%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+300%
|
21
+2 475%
|
17
-19%
|
12
-28%
|
8
-33%
|
6
-28%
|
6
+7%
|
17
+171%
|
25
+51%
|
44
+73%
|
60
+37%
|
42
-31%
|
85
+105%
|
60
-29%
|
112
+86%
|
192
+71%
|
238
+24%
|
376
+58%
|
470
+25%
|
851
+81%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
6
|
7
|
13
|
13
|
14
|
18
|
19
|
25
|
41
|
54
|
69
|
83
|
83
|
103
|
103
|
103
|
104
|
103
|
105
|
107
|
121
|
|